This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In this issue we present one more example of the harm which may befall newborn and premature infants from the administration of a drug known to be safe for older subjects. The list of agents harmful to these small human beings is growing longer. We have become aware of the dangers of oxygen, sulfisoxazole, sulfadiazine, chloramphenicol, and vitamin K. Sutherland and Keller in this issue add novobiocin to the list.
The dangers associated with each of these substances were found by chance, after death, blindness, or kernicterus had followed their widespread use. Drug houses and research laboratories have always tested new drugs, but usually only on animals and adult humans. It is finally apparent that such testing must be extended to premature and full-term infants and to newborn animals. A start has been made in this direction by Kent and his co-workers (this Journal, September, 1960) and by Michael and
DAY RL. Premature Pharmacology. Am J Dis Child. 1961;101(4):411–412. doi:10.1001/archpedi.1961.04020050001002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: